First Manhattan’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.85M Sell
80,427
-2,652
-3% -$236K 0.02% 204
2025
Q4
$6.56M Sell
83,079
-75
-0.1% -$5.88K 0.02% 206
2025
Q3
$6.65M Sell
83,154
-2,300
-3% -$196K 0.02% 204
2025
Q2
$7.77M Buy
85,454
+321
+0.4% +$29.3K 0.02% 188
2025
Q1
$7.98M Sell
85,133
-18,259
-18% -$1.63M 0.02% 170
2024
Q4
$9.42M Sell
103,392
-1,221
-1% -$117K 0.03% 155
2024
Q3
$10.9M Sell
104,613
-1,850
-2% -$189K 0.03% 138
2024
Q2
$10.3M Sell
106,463
-6,302
-6% -$581K 0.03% 142
2024
Q1
$10.2M Sell
112,765
-4,988
-4% -$423K 0.03% 149
2023
Q4
$9.14M Sell
117,753
-5,252
-4% -$395K 0.03% 154
2023
Q3
$8.53M Sell
123,005
-3,600
-3% -$269K 0.03% 157
2023
Q2
$9.45M Sell
126,605
-12,554
-9% -$972K 0.03% 148
2023
Q1
$10M Sell
139,159
-10,248
-7% -$762K 0.04% 143
2022
Q4
$11.3M Sell
149,407
-4,961
-3% -$372K 0.04% 139
2022
Q3
$10.4M Sell
154,368
-1,933
-1% -$152K 0.04% 142
2022
Q2
$12M Sell
156,301
-6,561
-4% -$513K 0.05% 136
2022
Q1
$12.3M Sell
162,862
-2,375
-1% -$188K 0.04% 155
2021
Q4
$14.1M Buy
165,237
+3,953
+2% +$309K 0.05% 141
2021
Q3
$12.2M Sell
161,284
-19,363
-11% -$1.54M 0.04% 141
2021
Q2
$14.7M Sell
180,647
-86
-0% -$7.03K 0.05% 135
2021
Q1
$14.2M Buy
180,733
+3,702
+2% +$290K 0.06% 132
2020
Q4
$15.1M Sell
177,031
-8,003
-4% -$662K 0.07% 124
2020
Q3
$14.3M Buy
185,034
+3,000
+2% +$229K 0.07% 122
2020
Q2
$13.3M Buy
182,034
+7,190
+4% +$511K 0.08% 123
2020
Q1
$11.6M Buy
174,844
+8,265
+5% +$583K 0.08% 132
2019
Q4
$11.5M Buy
166,579
+245
+0.1% +$16.7K 0.06% 154
2019
Q3
$12.2M Sell
166,334
-8,976
-5% -$651K 0.07% 152
2019
Q2
$12.6M Buy
175,310
+796
+0.5% +$56.5K 0.07% 146
2019
Q1
$12M Sell
174,514
-1,267
-0.7% -$81.8K 0.07% 149
2018
Q4
$10.5M Sell
175,781
-6,074
-3% -$380K 0.07% 164
2018
Q3
$12.2M Sell
181,855
-16,904
-9% -$1.13M 0.06% 167
2018
Q2
$12.9M Sell
198,759
-2,899
-1% -$190K 0.07% 162
2018
Q1
$14.5M Sell
201,658
-5,953
-3% -$428K 0.08% 153
2017
Q4
$15.7M Buy
207,611
+900
+0.4% +$65.7K 0.09% 152
2017
Q3
$15.1M Sell
206,711
-11,405
-5% -$822K 0.09% 152
2017
Q2
$16.2M Sell
218,116
-125
-0.1% -$9.28K 0.09% 144
2017
Q1
$16M Buy
218,241
+1,960
+0.9% +$137K 0.09% 137
2016
Q4
$14.2M Sell
216,281
-13,542
-6% -$929K 0.09% 147
2016
Q3
$17M Sell
229,823
-10,800
-4% -$798K 0.1% 134
2016
Q2
$17.6M Sell
240,623
-11,042
-4% -$786K 0.11% 130
2016
Q1
$17.8M Sell
251,665
-3,970
-2% -$264K 0.11% 126
2015
Q4
$17M Sell
255,635
-214
-0.1% -$14.2K 0.1% 130
2015
Q3
$16.2M Sell
255,849
-186
-0.1% -$12.2K 0.1% 125
2015
Q2
$16.7M Buy
256,035
+36
+0% +$2.44K 0.1% 129
2015
Q1
$17.8M Sell
255,999
-4,498
-2% -$311K 0.1% 129
2014
Q4
$18M Sell
260,497
-446
-0.2% -$30.1K 0.1% 129
2014
Q3
$17M Buy
260,943
+5,526
+2% +$364K 0.1% 130
2014
Q2
$17.4M Sell
255,417
-57
-0% -$3.82K 0.11% 130
2014
Q1
$16.6M Buy
255,474
+1,001
+0.4% +$63.1K 0.11% 131
2013
Q4
$16.6M Sell
254,473
-66
-0% -$4.22K 0.11% 134
2013
Q3
$15.1M Sell
254,539
-1,640
-0.6% -$97.2K 0.11% 132
2013
Q2
$15.4M Buy
+256,179
New +$15.2M 0.11% 129

Other funds holding CL

First Manhattan's CL Position: Q1 2026 in Review

First Manhattan reduced its Colgate-Palmolive (CL) stake by 3.2% in Q1 2026, selling an estimated $236K and leaving 80,427 shares worth $6.85M. The position accounts for 0.02% of the portfolio, ranked #204.

First Manhattan first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $18M in Q4 2014. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • First Manhattan held 80,427 shares of Colgate-Palmolive worth $6.85M as of Q1 2026.
  • First Manhattan sold 2,652 Colgate-Palmolive shares in Q1 2026, an estimated $236K.
  • Colgate-Palmolive made up 0.02% of First Manhattan's portfolio in Q1 2026, its #204 holding.
  • First Manhattan first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • First Manhattan's Colgate-Palmolive position peaked at $18M in Q4 2014.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on First Manhattan's 13F filing for Q1 2026, filed 15 May 2026.